AgelessRx announced the launch of its new Methylene Blue product, developed to support cognitive longevity and mitochondrial function. According to the company, the offering aims to make evidence-informed cognitive health interventions more accessible to consumers.
The company said Methylene Blue has been studied for its potential to enhance cellular energy production, reduce oxidative stress, and protect brain health. AgelessRx claims its formulation is designed to deliver low, controlled doses intended for daily use as part of a broader longevity strategy.
According to the company, Methylene Blue may help maintain memory and attention by improving mitochondrial efficiency and supporting neural resilience. AgelessRx said the product aligns with its focus on translating promising scientific research into practical tools to slow age-related cognitive decline.
The company claims this launch is part of a wider portfolio expansion into therapies targeting longevity and brain health. AgelessRx noted that it also offers prescription and non-prescription products intended to address key hallmarks of aging.
AgelessRx said it will continue to monitor scientific developments and clinical data to refine its product offerings. The company claims its mission remains to bring forward safe, research-backed solutions that empower individuals to proactively manage cognitive health and aging.
